Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

1-deamino-8-D-arginine vasopressin and cryoprecipitate in variant von Willebrand disease

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Hanna, W. T.
  • Slywka, J.
  • Dent, J.
  • Ruggeri, Zaverio
  • Zimmerman, T. S.

publication date

  • 1985

journal

  • American Journal of Hematology  Journal

abstract

  • The effect of infusing DDAVP and cryoprecipitate either singly or in combination was studied in a patient with variant von Willebrand disease. Both DDAVP and cryoprecipitate caused only partial correction in the hemostatic defect when used as a single agent. A combination of DDAVP and cryoprecipitate induced a complete correction of the hemostatic defect as well as factor VIII related properties.

subject areas

  • Deamino Arginine Vasopressin
  • Drug Therapy, Combination
  • Factor VIII
  • Fibrinogen
  • Genetic Variation
  • Humans
  • Infusions, Parenteral
  • Male
  • Middle Aged
  • von Willebrand Diseases
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0361-8609

Digital Object Identifier (DOI)

  • 10.1002/ajh.2830200210

PubMed ID

  • 3929596
scroll to property group menus

Additional Document Info

start page

  • 169

end page

  • 173

volume

  • 20

issue

  • 2

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support